Zuojun Wu
About Zuojun Wu
Zuojun Wu is the Manager of Statistical Programming at Bristol Myers Squibb in Lawrence, New Jersey, with over four years of experience in clinical trial statistical programming.
Company
Zuojun Wu currently works at Bristol Myers Squibb, a leading global biopharmaceutical company. As the Manager of Statistical Programming, he is based in Lawrence, New Jersey, United States. Bristol Myers Squibb is known for its commitment to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Zuojun Wu holds the position of Manager, Statistical Programming at Bristol Myers Squibb. In this role, he oversees various aspects of statistical programming, ensuring the efficient and accurate analysis of clinical trial data.
Previous Work Experience
Prior to joining Bristol Myers Squibb in May 2021, Zuojun Wu worked for three years at Brightech International as a Statistical Programmer. His role at Brightech, which is located in Somerset, New Jersey, involved critical statistical programming tasks associated with clinical trials.
Education and Expertise
Zuojun Wu has a solid academic foundation with extensive education in both biostatistics and nutrition sciences. He earned a Master of Arts (M.A.) in Biostatistics from the University at Buffalo between 2016 and 2018. He also received a Master’s Degree in Nutrition Sciences from the University at Buffalo from 2013 to 2015. Before that, he completed a Bachelor of Science (BS) in Nutrition Sciences at Shanghai Jiao Tong University from 2009 to 2013.
Proficiency in SAS Programming
Zuojun Wu is proficient in multiple SAS programming modules, including Base SAS, SAS/SQL, SAS/MACROS, SAS/ODS, and SAS/GRAPH. His skills in these areas contribute significantly to his effectiveness in statistical programming and his ability to manage complex clinical trial data sets.
Experience in Clinical Trial Statistical Programming
Zuojun Wu has over 4 years of experience specifically in clinical trial statistical programming. His expertise ensures the accurate analysis and reporting of clinical trial data, which is essential for the development of new medical treatments.